Campylobacter vaccine development:a key to controlling enteric diseases

Bibliography

• TAYLOR DN: biCampylobacter infections in developing countries. In: Campylobacterjejuni: Current Status and Future Trends. Nachamkin I, Blaser MJ, Tompkins LS (Eds.), American Society for Microbiology, Washington, DC, USA (1992):20–30.
   Google Scholar
• TAUXE RV: Epidemiology of Campylobacterjejuni in-fections in the United States and other Industrialized nations. In: Campylobacterjejuni: Current Status and Fu-ture Trends. Nachamkin I, Blaser MJ, Tompkins LS (Eds.), American Society for Microbiology, Washington, DC, USA (1992):9–19.
   Google Scholar
• DUPONT HL, KHAN FM: Travellers' diarrhoea: epidemi-ology microbiology, prevention, and therapy. J. Travel Med. (1994) 1:84–93.
   PubMedGoogle Scholar
• ECHEVERRIA P, JACKSON LR, HOGE CW et al.: Diarrhoea in US troops deployed to Thailand. J. Clin. Microbic)]. (1993) 31:3351–3352.
   PubMed Web of Science ®Google Scholar
• MURPHY GS, ECHEVERRIA P, JACKSON LR et al.: Cipro-floxacin- and azithromycin-resistant Campylobacter causing travellers' diarrhoea in US troops deployed to Thailand in 1994. Clin. Infect. Dis. (1996) 22:868–869.
   PubMed Web of Science ®Google Scholar
• KUSCHNER RA, TROFA AF, THOMAS RJ et al.: Use ofazithromycin for the treatment of Campylobacter en-teritis in travellers to Thailand, an area where cipro-floxacin resistance is prevalent. Clin. Infect. Dis. (1995) 21:536–541.
   PubMed Web of Science ®Google Scholar
• HABERBERGER RL JR, WALKER RI: Prospects and prob-lems for development of a vaccine against diarrhoea caused by Campylobacter. Vaccine Res. (1994) 3:15–22.
   Google Scholar
• ••First review to examine vaccine options for Campylobacter.
   Google Scholar
• SEATTLE-KING COUNTY DEPARTMENT OF PUBLICHEALTH: Surveillance of the flow of Salmonella and Campylobacterin a community. In: Communicable Dis-ease Control Section. Seattle: Seattle-King County Depart-ment of Public Health (1984).
   Google Scholar
• MACDONALD KL, O'LEARY MJ, COHEN ML et al.: Escheri-chia coli 0157:H7, an emerging gastrointestinal patho-gen. Results of a one year prospective, population-based study. JAMA (1988) 259:3567–3570.
   Google Scholar
• BLASER MJ, WELLS JG, FELDMAN RA, POLLARD, RA, AL-LAN JR: Campylobacter enteritis in the United States. A multicenter study. Ann. Intern. Med. (1983) 98:360–365.
   PubMed Web of Science ®Google Scholar
• FARTHING MJ: Traveller's diarrhoea. Br. J. Hosp. Med. (1992) 48:82–92.
   PubMedGoogle Scholar
• MATTILA L, SIITONEN A, KYROSEPPA H et al: Seasonal variation in etiology of travellers' diarrhoea. Finnish J. Infect. Dis. (1992) 165:385–388.
   PubMed Web of Science ®Google Scholar
• MATTILA L: Clinical features and duration of travellers' diarrhoea in relation to its etiology. Clin. Infect. Dis. (1994) 19:728–734.
   PubMed Web of Science ®Google Scholar
• SPEELMAN P, STRUELANS MJ, SANYAL SC, GLASS RI: De-tection of Campylobacter jejuni and other potential pathogens in travellers' diarrhoea in Bangladesh. Scand. I Gastroenterol. (1983) 84 Suppl.:S19–S23.
   Google Scholar
• TAYLOR DN, ECHEVERRIA P: Etiology and etiology of travellers' diarrhoea in Asia. Rev. Infect. Dis. (1986) 8 Suppl. 2:S136–S141.
   Google Scholar
• TAYLOR DN, ECHEVERRIA P, BLASER MJ et al: Polymi-crobial etiology of travellers' diarrhoea. Lancet (1985) 1 :381–383.
   PubMed Web of Science ®Google Scholar
• MISHU B, BLASER MJ: Role of infection due to Campylo-bacterjejuni in the initiation of Guillain-Barre syn-drome. Clin. Infect. Dis. (1993) 17:104–108.
   PubMed Web of Science ®Google Scholar
• KUROKI S, HARUTA T, YOSHIOKA M, KOBAYASHI Y, NUKINA M, NAKANISHI H: Guillain-Barre syndrome as-sociated with Campylobacter infection. Pediatr. Infect. Dis. J. (1991) 10:149–151.
   PubMed Web of Science ®Google Scholar
• MISHU B, ILYAS AA, KOSKI CL et al: Serologic evidenceof previous Campylobacterjejuniinfection in patients with Guillain-Barre syndrome. Ann. Intern. Med. (1993) 118:947–953.
   PubMed Web of Science ®Google Scholar
• REES JH, SOUDAIN SE, GREGSON NA, HUGHES RAC: Campylobacter jejuni infection and Guillain-Barre syndrome. N Engl. J. Med.. (1995) 333:1374–1379.
   PubMed Web of Science ®Google Scholar
• BLASER MJ, MISHU-ALLOS B, LANGE D: Development of Guillain-Barre syndrome following Campylobacterin-fection. J. Infect. Dis. (1997) 176 (Suppl. 2):591.
   Google Scholar
• SKIRROW MB, BLASER MJ: Clinical and epidemiologic considerations. In: Campylobacterjejuni: Current Status and Future Trends. Nachamkin I, Blaser MJ, Tompkins LS (Eds.), American Society Microbiology, Washington, DC, USA (1992):3–8.
   Google Scholar
• BLASER MJ, RELLER LB: Campylobacterenteritis. N Engl. J. Med. (1981) 305:1444–1452.
   PubMed Web of Science ®Google Scholar
• BLACK RE, LEVINE MM, CLEMENTS ML, HUGHES TP, BLA-SER MJ: Experimental Campylobacterjejuni infection in humans. J. Infect. Dis. (1988) 157:472–479.
   PubMed Web of Science ®Google Scholar
• BLACK RE, PERLMAN D, CLEMENTS ML, LEVINE MM, BLA-SER MJ: Human volunteer studies with Campylobacter jejuni infection in humans. In: Campylobacter jejuni: Current Status and Future Trends. Nachamkin I, Blaser MJ, Tompkins LS (Eds.), American Society Microbiology, Wash-ington, DC, USA (1992):201–215.
   Google Scholar
• CALVA JJ, RUIZ-PALACIOS GM, LOPEZ-VIDAL AB, RAMOSA, BOJALIL R: Cohort study of intestinal infection with Campylobacter in Mexican children. Lancet (1988) 1:503–506.
   PubMed Web of Science ®Google Scholar
• PAZZAGLIA G, BOURGEOIS AL, EL DIWANY K, NOUR N,BADRAN N, HABLAS R: Campylobacter diarrhoea and an association of recent disease with asymptomatic shedding in Egyptian children. Epidemic)]. Infect. (1991) 106:7782.
   Google Scholar
• BLASER MJ, BERKOWITZ ID, LAFORCE M, CRAVENS J, REL-LER LB, WANG WI: Campylobacterenteritis clinical and epidemiologic features. Ann. Intern. Med. (1979) 91:179–185.
   PubMed Web of Science ®Google Scholar
• WALKER RI, CALDWELL MB, LEE EC et al.: Pathophysiol-ogy of Campylobacter enteritis. Microbiol Rev. (1986) 50:81–94.
   PubMedGoogle Scholar
• •Good overview of the bacteria and its pathogenesis.
   Google Scholar
• Chicken: what you don't know can hurt you. Consumer Reports (1988) March:12–18.
   Google Scholar
• PETRUCCELLI BP, MURPHY GS, SNACHEZ JL et al.: Treat-ment of traveller's diarrhoea with ciprofloxacin and loperamide. I Infect. Dis. (1992) 165:557–560.
   PubMed Web of Science ®Google Scholar
• ENDTZ HP, RUIJS GJ, VAN KLINGEREN B, JANSEN WH, VAN DER REYDEN T, MOUTON RP: Quinolone resis-tance in Campylobacter isolated from man and poul-try following the introduction of flouroquinolones in veterinary medicine. J. Antimicrob. Chemother. (1991) 27:199–208.
   PubMed Web of Science ®Google Scholar
• REINA J, BORRELL N, SERRA A: Emergence of resistanceto erythromycin and fluoroquinolones in thermotol-erant Campylobacter strains isolated from feces, 1987-1991. Eur. j Clin. Microbiol. Infect. Dis. (1992) 11:1163–1166.
   PubMed Web of Science ®Google Scholar
• RICE BE, ROLLINS DM, MALLINSON ET et al.: Campylo-bacterjejuni in broiler chickens: colonisation and hu-moral immunity following oral vaccination and experimental infection. Vaccine (1997) 15:1922–1932.
   PubMed Web of Science ®Google Scholar
• PATTON CM, WACHSMUTH IK: Typing schemes: are current methods useful? In: Campylobacter Muni: Cur-rent Status and Future Trends. Nachamkin I, Blaser MJ, Tompkins LS (Eds.) American Society for Microbiology, Washington, DC, USA (1992):110–130.
   Google Scholar
• LIOR H, WOODWARD DL, EDGAR JA, LAROCHE LI GILL P: Serotyping of Campylobacterjejuniby slide agglutina-tion based on heat-labile antigenic factors. J. Clin. Mi-crobiol. (1982) 15:761–768.
   PubMed Web of Science ®Google Scholar
• PENNER JL, HENNESSY JN: Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejunion the basis of heat-stable antigens. J. Clin. Micro-biol. (1980) 12:732–737.
   PubMed Web of Science ®Google Scholar
• PAVLOVSKIS OR, ROLLINS DM, HABERBERGER RL JR: Sig-nificance of flagella in colonisation resistance of rab-bits immunised with Campylobacter spp. Infect. Immun. (1991) 59:2259–2264.
   PubMed Web of Science ®Google Scholar
• GEORGES-COURBOT MC, BERAUD-CASSEL AM, GOUANDJIKA I, GEORGES AJ: Prospective study of en-teric Campylobacter infections in children from birth to 6 months in the Central African Republic. J. Clin. Mi-crobiol. (1987) 25:836–839.
   PubMed Web of Science ®Google Scholar
• TAYLOR DN, ECHEVERRIA P, PITARANGSI C et al.: Influ-ence of strain characteristics and immunity on the epi-demiology of Campylobacter infection in Thailand. J. Clin. Microbic)]. (1988) 26:863–868.
   PubMed Web of Science ®Google Scholar
• WENMAN WM, CHAT J, LOUIE TJ et al.: Antigenic analysisof Campylobacter flagellar proteins and other pro-teins. J. Clin. Microbiol. (1985) 21:108–112.
   PubMed Web of Science ®Google Scholar
• POWER ME, GUERRY P, MCCUBBIN WD, KAY CM, TRUSTTJ: Structural and antigenic characteristics of Campy-lobacter coli FlaA flagellin. J. Bacteriol. (1994) 176:3303–3313.
   PubMed Web of Science ®Google Scholar
• GUERRY P, DOIG P, ALM RA, BURR DH, KINSELLA N, TRUST TJ: Identification and characterization of genes required for posttranslational modification of Campy-lobacter coli VC167 flagellin. Mol. Microbiol. (1996) 19:369–378.
   PubMed Web of Science ®Google Scholar
• DOIG P, KINSELLA N, GUERRY P, TRUST TJ: Characteriza-tion of posttranslational modification of Campylobac-ter flagellin: identification of serospecific glycosyl moiety. Mol. Microbic]. (1996) 19:379–387.
   PubMed Web of Science ®Google Scholar
• BLASER MJ, HOPKINS JA, VASIL ML: Campylobacter je-juni outer membrane proteins are antigenic for hu-mans. Infect. Immun. (1984) 43:986–993.
   PubMed Web of Science ®Google Scholar
• LOGAN SM, TRUST TJ: Outer membrane characteriza-tion of Campylobacter jejuni. Infect. Immun. (1982) 38:898–894.
   PubMed Web of Science ®Google Scholar
• PEI Z, BLASER MJ: PEB1, the major cell-binding factor ofCampylobacter jejuni, is a homolog of the binding component in gram-negative nutrient transport sys-tems. J. Biol. Chem. (1993) 268:18,717–718,725.
   Google Scholar
• DOIG P, YAO R, BURR DH, GUERRY P, TRUST TJ: An envi-ronmentally regulated pilus-like appendage involved in Campylobacter pathogenesis. Mol. Microbiol. (1996) 20:885–894.
   PubMed Web of Science ®Google Scholar
• KONKEL ME, MEAD D, CIEPLAK W JR: Kinetic and anti-genic characterization of altered protein synthesis by Campylobacterjejuni during cultivation with human epithelial cells. J. Infect. Dis. (1993) 168:948–954.
   PubMed Web of Science ®Google Scholar
• PANIGRAHI P, LOSONSKY G, DETOLLA LJ, MORRIS JG JR:Human immune response to Campylobacter jejuni proteins expressed in vivo. Infect. Immun. (1992) 60:4938–4944.
   PubMed Web of Science ®Google Scholar
• TAYLOR DE: Genetics of Campylobacter and Helico-bacter. Annu. Rev. Microbic]. (1992) 46:35–64.
   PubMed Web of Science ®Google Scholar
• YAO R, BURR DH, DOIG P, TRUST TJ, NIU H, GUERRY P:Isolation of motile and non-motile insertional mu-tants of Campylobacterjejuni: the role of motility in adherence and invasion of eukaryotic cells. Mol. Micro-biol. (1994) 14:883–893.
   PubMed Web of Science ®Google Scholar
• PACE J, FREY S, WALKER R, ESPOSITO V: Culture of Cam-pylobacterjejuniwith bile induces alterations of viru-lence indices. Infect. Imm. (Submitted).
   Google Scholar
• WALKER RI, SCHMAUDER-CHOCK EA, PARKER JL, BURR D: Selective association and transport of Campylobac-ter jejuni through M cells of rabbit Peyer's patches. Can. J. Microbic)]. (1988) 34:1142–1147.
   PubMed Web of Science ®Google Scholar
• BURR DH, CALD WELL MB, BOURGEOIS AL et al.: Mucosaland systemic immunity to Campylobacter jejuni in rabbits after gastric inoculation. Infect. Immun. (1988) 56:99–105.
   PubMed Web of Science ®Google Scholar
• MCSWEEGAN E, BURR DH, WALKER RI: Intestinal mucus gel and secretory antibody are barriers to Campylo-bacterjejuni adherence to INT 407 cells. Infect. Immun. (1987) 55:1431–1435.
   PubMed Web of Science ®Google Scholar
• WALKER RI: New strategies for using mucosal vaccina-tion to achieve more effective immunisation. Vaccine (1994) 12:387–400.
   PubMed Web of Science ®Google Scholar
• ••Broad review of approaches to development of mucosalvaccines.
   Google Scholar
• CARDENAS L, DASGUPTA U, CLEMENTS JD: Influence of strain viability and antigen dose on the use of attenu-ated mutants of Salmonella as vaccine carriers. Vaccine (1994) 12:833–840.
   PubMed Web of Science ®Google Scholar
• CHEN K-S, QUINNAN GV JR: Introduction, persistance and strain specificity of hemagglutination-specific se-cretory antibodies in lungs of mice after intragastric administration of inactivated influenza virus vaccines. J. Gen. Virol. (1988) 69:2779–2784.
   PubMedGoogle Scholar
• WALKER RI, CLEMENTS JD: Use of heat-labile toxin of enterotoxigenic Escherichia coli to facilitate mucosal immunisation. Vaccine Research (1993) 2:1–10.
   Google Scholar
• •In-depth review of this mucosal adjuvant and its possibleuse in vaccines.
   Google Scholar
• BAQAR S, APPLEBEE LA, BOURGEOIS AL: Immunogenic-ity and protective efficacy of a prototype Campylobac-ter killed whole-cell vaccine in mice. Infect. Immun. (1995) 63:3731–3735.
   PubMed Web of Science ®Google Scholar
• TRIBBLE DR, BAQAR S, OPLINGER ML et al.: Safety and immunogenicity of an oral, inactivated whole cell Campylobactervaccine coadministered with modified Escherichia coli heat-labile enterotoxin (LTR1920 ad-juvant in volunteers. Interscience Conf Antimicr. Agents Chemother. 1997, Toronto, Canada.
   Google Scholar
• SCOTT DA: Vaccines against Campylobacter jejuni. J. Infect. Dis. (1997) 176 (Suppl. 2):S183–S188.
   Google Scholar
• ••This review provides an excellent update on Campylobactervaccine development. Patents
   Google Scholar